In conclusion, this study reveals that the synergistic combination of RG3 and CTD suppresses HCC progression through dual inhibition of SREBF1-mediated lipogenesis via PI3K/AKT/mTOR signaling and PRMT1-dependent post-translational regulation. The gene discussed is AKT1; the disease is hepatocellular carcinoma.